Olympus medical systems corp.(omsc) received a literature titled, "comparing endoscopic ultrasound-guided antegrade treatment and balloon endoscopy-assisted endoscopic retrograde cholangiopancreatography in the management of bile duct stones in patients with surgically altered anatomy: a retrospective cohort study".Endoscopic ultrasound-guided antegrade treatment (eus-ag) and balloon endoscopy-assisted endoscopic retrograde cholangiopancreatography (be-ercp) have emerged as useful procedures for managing bile duct stones (bds) in patients with surgically altered anatomy.However, the comparison between these two procedures has not been well studied.The aim of our study was to compare the clinical outcomes of eus-ag and beercp for managing bds in patients with surgically altered anatomy.Type of adverse events/number of patients: event1: bile peritonitis(n=3).Event2: elevation of c-reactive protein(n=1).Event3: pancreatitis (n=3).Event4: perforation (n=4).The following procedure and olympus devices are used in this literature.(1) eus-ag: convex-type eus scope (gf-uct260).Fine-needle aspiration (fna) needle (ez shot 3 plus : estimated as na-u200h-8019).Retrieval balloon catheter (multi-3 v plus : estimated as b-v232p-b).Ercp scope (tjf 260 or tjf 290).Mechanical lithotripsy (ml: lithocrushv : estimated as bml-v437qr-30).(2) be-ercp: 0.025-inch guidewire (visiglide 2).Extraction balloon (multi-3 v plus).Lithocrushv.Ultra-slim endoscope (gif-xp260n or gif-xp290n).The following events have been reported in the literature: (refer to table 3 of the literature).Event1: bile peritonitis(n=3) : occurred in eus-ag.Event2: elevation of c-reactive protein (n=1) : occurred in eus-ag.Event3: pancreatitis (n=3) : occurred in be-ercp.Event4: perforation (n=4) : occurred in be-ercp.Three patients with perforation after be-ercp experienced severe adverse events, necessitating surgery in one and clip closure in two.A moderate case occurred in one patient with bile peritonitis after eus-ag who required an additional procedure using be-ercp to place an endoscopic nasobiliary drainage.This event requires eight reports with patient identifiers: - devices used for eus-ag and be-ercp: (1) (b)(4).B-v232p-b (event 1,2,3,4): (2) (b)(4).Bml-v437qr-30 (event 1,2,3,4): - devices used for eus-ag: (3) (b)(4).Gf-uct260 (event 1,2).(4) (b)(4).Na-u200h-8019 (event 1,2).(5) (b)(4).Tjf-260v (event 1,2).(6) (b)(4).Tjf-q290v (event 1,2).- devices used for be-ercp: (7) (b)(4).Gif-xp260n (event 3,4).(8) (b)(4).Gif-xp290n (event 3,4).This report is for (b)(4).
|
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation and to provide additional information received from the author.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.In addition, based on the clinical/medical evaluation and risk assessment, it is possible that the reported event is an accident, or a complication associated with a procedure using the subject device.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|